Nortis

About:

Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.

Website: http://nortisbio.com

Twitter/X: nortisinc

Top Investors: National Institutes of Health

Description:

Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of a human micro-tissue environment within small, disposable, microfluidic chips. The company's technology enables living models of human organs that will drastically accelerate the discovery and introduction of new therapies and alleviate the use of lab animals. By growing tissue from human organ systems inside small microfluidic chips, researchers and assay developers can conduct in-vitro testing directly on functional human tissues. Nortis was founded in 2012 and is headquartered in Woodinville, Washington.

Total Funding Amount:

$13.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woodinville, Washington, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)nortisbio.com

Founders:

Alan Nelson, Thomas Neumann

Number of Employees:

11-50

Last Funding Date:

2022-08-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai